Cargando…
Management of Pharmacologic Adverse Effects in Advanced Liver Disease
As a consequence of the altered hepatic architecture in advanced liver disease, drug metabolism is modified by changes in pharmacokinetic and pharmacodynamic properties, leading to the appearance of adverse effects and drug interactions and increasing the risk of over- or underdosing of medications....
Autores principales: | García-Cortés, Miren, García-García, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205818/ https://www.ncbi.nlm.nih.gov/pubmed/35522395 http://dx.doi.org/10.1007/s40261-022-01150-w |
Ejemplares similares
-
Management of Hepatic Encephalopathy Associated with Advanced Liver Disease
por: García-Martínez, Rita, et al.
Publicado: (2022) -
Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury
por: Caballano-Infantes, Estefanía, et al.
Publicado: (2021) -
Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019) -
Recent advances in the pharmacological management of migraine
por: Pascual, Julio
Publicado: (2009) -
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
por: Espina, Silvia, et al.
Publicado: (2023)